Today: 9 June 2026
RBA rate call hangs on CPI: Big banks split as Australia inflation data looms
27 January 2026
2 mins read

RBA rate call hangs on CPI: Big banks split as Australia inflation data looms

SYDNEY, Jan 27, 2026, 18:56 (AEDT)

  • Commonwealth Bank expects underlying inflation to remain high, leaving the door open for a rate hike in February
  • On Wednesday, ABS will release December CPI and December-quarter data, just ahead of the RBA’s meeting on Feb 2–3
  • Westpac and ANZ predict easing inflation; both investors and borrowers focus on the “trimmed mean” measure

Australia’s interest-rate outlook narrowed sharply Tuesday, after Commonwealth Bank signaled underlying inflation could come in hotter than expected. The update revived the possibility of a rate hike from the Reserve Bank of Australia as soon as February.

The inflation report set for Wednesday is the final key data before the RBA’s Feb. 2–3 meeting, arriving as household budgets are under pressure. Markets have swung sharply between “hold” and “hike” bets, with tiny shifts in inflation numbers tipping the scales.

The trimmed mean—the inflation gauge that excludes the most extreme price changes—is the key focus. Investors keep a close eye on it since it usually reflects ongoing price pressures more reliably than the headline CPI, which can jump around due to fuel costs or seasonal factors.

Commonwealth Bank’s economics team expects the quarterly trimmed mean to climb 0.9% in the December quarter, noting this pace remains “well above” what would align with the RBA’s goal of bringing inflation back to 2–3%. They also predict annual trimmed-mean inflation will rise to 3.3%, with headline inflation hitting 3.8% year-on-year for December—higher than the 3.6% consensus they referenced. https://www.realestate.com.au/news/rates-o…

Economists and traders see the upcoming CPI report as a critical juncture. Betashares chief economist David Bassanese described it as a “make or break” for mortgage holders, predicting a 0.8% quarterly trimmed mean increase that “should be enough to keep the RBA sidelined in February.” But if inflation runs hotter, that could force the Reserve Bank into action. VanEck’s Jamie Hannah noted the earlier slowdown might “keep the rate hike wolves at bay for now.” Meanwhile, State Street Investment Management APAC economist Krishna Bhimavarapu cautioned that volatility may linger as stimulus fades and the central bank waits on clearer signals. https://www.investordaily.com.au/cpi-print…

Borrowers feel the impact sharply. Since most home loans carry variable rates, an RBA rate hike usually translates swiftly into higher repayments. Canstar calculates that a 0.25 percentage point increase would tack on roughly A$90 monthly for a A$600,000 mortgage, A$112 for A$750,000, and A$150 on a A$1 million loan.

Markets are holding steady as they await the inflation figures. Australian equity futures suggest a quiet start, with investors bracing for data that could reshape expectations not only for the next RBA move but also the trajectory beyond.

The unease isn’t confined to trading floors. Local media are portraying the upcoming decision as a potential strain on household and business budgets, with inflation data taking center stage.

The downside risk to rate-hike bets is straightforward: inflation data can be volatile, and a weaker trimmed-mean reading would challenge the view that price pressures are picking up again. Many forecasters are calling for a quarterly trimmed mean around 0.7%–0.8%; if it comes in near the lower bound, the RBA might decide to hold its ground and wait it out.

The ABS last put annual CPI inflation at 3.4% in November, with trimmed-mean inflation at 3.2%, both still above the RBA’s preferred range. The bureau has now made the monthly CPI its main headline measure. It’s set to release December CPI figures on Wednesday, Jan. 28, along with December-quarter tables derived from the monthly data.

The RBA’s cash rate target stands at 3.60%, per the central bank’s latest release. Updates come at 2:30 p.m. following board meetings, with the next call expected after the Feb. 2–3 session.

The banks remain divided, and so is the market. Wednesday’s trimmed-mean figure — just a few tenths in either direction — will probably determine if the RBA holds steady or moves to tighten once more, and how fast that decision filters down to mortgages and asset prices.

Stock Market Today

  • Hexagon Nutrition IPO Oversubscribed by 54x; NLC OFS and NSE CSR Initiative Highlight Market Activity
    June 9, 2026, 10:07 AM EDT. Hexagon Nutrition's initial public offering (IPO) drew robust interest, oversubscribed 54 times, signaling strong investor demand. Meanwhile, NLC India's Offer for Sale (OFS) also exceeded subscription targets. In parallel, the National Stock Exchange (NSE) announced a commitment to corporate social responsibility (CSR) efforts through support for the Social Stock Exchange, marking a notable blend of market activity and social initiatives.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Exxon Mobil stock dips after hours as Baytown freeze and carbon-capture launch set up earnings week
Previous Story

Exxon Mobil stock dips after hours as Baytown freeze and carbon-capture launch set up earnings week

Lloyds share price today: LLOY.L ticks higher as sanctions fine fades and results loom
Next Story

Lloyds share price today: LLOY.L ticks higher as sanctions fine fades and results loom

Go toTop